Last Price
0.495
Today's Change
-0.005 (1.01%)
Day's Change
0.49 - 0.495
Trading Volume
51,373
Market Cap
66 Million
Shares Outstanding
134 Million
Avg Volume
144,409
Avg Price (50 Days)
0.41
Avg Price (200 Days)
0.35
PE Ratio
16.50
EPS
0.03
Earnings Announcement
13-Feb-2025
Previous Close
0.49
Open
0.49
Day's Range
0.49 - 0.495
Year Range
0.29 - 0.52
Trading Volume
51,373
1 Day Change
-1.01%
5 Day Change
6.45%
1 Month Change
15.12%
3 Month Change
54.69%
6 Month Change
54.69%
Ytd Change
22.22%
1 Year Change
25.32%
3 Year Change
-25.00%
5 Year Change
106.25%
10 Year Change
-21.43%
Max Change
-32.19%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. It manufactures a range of critical biological materials for the diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment and proficiency (QAPs) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows. The company also applies its biological expertise and infrastructure to develop other proprietary products, primarily viral transport medium (DxTM) to stabilize patient samples for lab-based testing and Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots. It sells QAPs to lab accreditation organizations, diagnostics companies, and clinical labs through a network of regional distributors. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.